Sapience Therapeutics, Inc.

Get Full Access

Description

  • Sapience Therapeutics is a preclinical-stage biotechnology company focused on advancing novel therapeutics for major unmet medical needs, particularly high mortality cancers. Our drug development program involves translating science into novel therapies, and our initial goal is to develop a first-in-class treatment for glioblastoma multiforme (GBM), which is the most severe and deadly form of brain cancer.Our strategy is to develop novel therapeutic agents that dramatically improve patient survival in high mortality cancers. We seek to develop therapies that have synergistic or additive effects with current therapies, and we intend to develop our drugs to be used in combination with other approved cancer treatments.Elements of our strategy include: - Development of our lead product candidate, ST-36, in GBM, the most severe form of brain cancer, initially to improve response rates and progression-free survival in combination with existing standards of care - Assessment of the impact of ST-36 on additional tumor types - Evaluation of in-licensing opportunities that fit our oncology and high unmet need focus to potentially expand our pipeline
  • location

    Headquarters:2 Overhill Road Suite 400, Scarsdale, New York, United States

    More
  • Sapience Therapeutics, Inc. phone

    Phone Number:

  • Sapience Therapeutics, Inc. website

    Website: https://www.sapiencetherapeutics.com

  • Sapience Therapeutics, Inc. employees

    Employees:11

  • Sapience Therapeutics, Inc. revenue

    Revenue:$10 - 50M

  • Sapience Therapeutics, Inc. legal name

    Legal Name:Sapience Therapeutics, Inc.

  • Sapience Therapeutics, Inc.'s Social Media

    Sapience Therapeutics, Inc. linkedin
  • done Is this data correct?
  • |  NAICS Code: 523110  |

    Show More
Person level website identification

CEO for Sapience Therapeutics, Inc.

Barry Kappel

Founder, President And Chief Executive Officer

Person level website visitor identification

Sell more in less time!

Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

View Employees

Nancy Dong

Senior Vice President, Finance And Administration

Jim Rotolo

Vice President Of Translational Pharmacology, Head Of Research

Gina Capiaux

Head Of Regulatory Affairs

Gene Merutka

Head Of Cmc

Lila Ghamsari

Director Of Discovery Science

Frequently Asked Questions regarding Sapience Therapeutics, Inc.

  • Where are Sapience Therapeutics, Inc.'s Headquarters?

    Sapience Therapeutics, Inc.'s Headquarters are in 2 Overhill Road Suite 400,Scarsdale,New York,United States

  • What is Sapience Therapeutics, Inc.'s official website?

    Sapience Therapeutics, Inc.'s official website is https://www.sapiencetherapeutics.com

  • What is Sapience Therapeutics, Inc.'s Revenue?

    Sapience Therapeutics, Inc.'s revenue is $10 - 50M

  • What is Sapience Therapeutics, Inc.'s NAICS code?

    Sapience Therapeutics, Inc.'s NAICS code is 523110

  • How many employees are working in Sapience Therapeutics, Inc.

    Sapience Therapeutics, Inc. has 11 employees

  • What is Sapience Therapeutics, Inc.'s Industry?

    Sapience Therapeutics, Inc. is in the industry of Biotechnology

  • Who is Sapience Therapeutics, Inc.'s CEO?

    Sapience Therapeutics, Inc.'s CEO is Barry Kappel

  • Who is Sapience Therapeutics, Inc.'s Senior Vice President, Finance And Administration?

    Sapience Therapeutics, Inc.'s Senior Vice President, Finance And Administration is Nancy Dong

Company Directory